In their quest to disable androgen receptor variants that drive castration-resistant prostate cancer, Richters et al. (2020) have hit upon a selective inhibitor of a transcriptional kinase that enables full-length mRNA synthesis. Drugging this essential kinase curbs tumor growth, thus making it an attractive focal target for transcription therapy. Copyright © 2021 Elsevier Ltd. All rights reserved.
Aseem Z Ansari. Blocking the Enablers: Selective Inhibition of CDK9 Reins in an Unchecked Master Regulator. Cell chemical biology. 2021 Feb 18;28(2):113-115
PMID: 33607002
View Full Text